Hi-Tech Loses Motion And Now Awaits FDA Decision
By Jesse Greenspan · October 14, 2008, 12:00 AM EDT
A federal judge has rejected Hi-Tech Pharmacal Co. Inc.'s motion for a preliminary injunction that would have prevented other drugmakers from marketing a generic version of the glaucoma drug Cosopt until...
To view the full article, register now.